Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Artivion Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
AORT
New York
3841
https://artivion.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Artivion Inc
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
- Apr 22nd, 2024 8:10 pm
Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year
- Apr 19th, 2024 1:10 pm
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
- Apr 15th, 2024 1:40 pm
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Apr 1st, 2024 8:10 pm
Are Medical Stocks Lagging Artivion (AORT) This Year?
- Mar 28th, 2024 1:40 pm
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?
- Mar 12th, 2024 1:40 pm
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- Mar 6th, 2024 9:10 pm
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
- Feb 22nd, 2024 2:15 pm
Wall Street Analysts Think Artivion (AORT) Could Surge 30.7%: Read This Before Placing a Bet
- Feb 21st, 2024 2:55 pm
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 15th, 2024 9:05 pm
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
- Feb 1st, 2024 9:10 pm
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
- Jan 29th, 2024 1:25 pm
Artivion Obtains $350 Million in Senior Secured Credit Facilities
- Jan 18th, 2024 9:05 pm
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer
- Dec 6th, 2023 9:15 pm
Artivion Announces Completion of Enrollment in PERSEVERE Trial
- Nov 9th, 2023 1:25 pm
Artivion to Participate in Upcoming Investor Conferences
- Nov 8th, 2023 9:05 pm
Artivion Reports Third Quarter 2023 Financial Results
- Nov 2nd, 2023 8:05 pm
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
- Oct 19th, 2023 8:10 pm
Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin
- Oct 5th, 2023 8:15 pm
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting
- Oct 5th, 2023 8:05 pm
Scroll